Published in Cancer Detect Prev on January 01, 1994
Exosomes as a tumor immune escape mechanism: possible therapeutic implications. J Transl Med (2008) 1.28
Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study. BMJ (2010) 1.18
Mutagenic and cytotoxic properties of 6-thioguanine, S6-methylthioguanine, and guanine-S6-sulfonic acid. J Biol Chem (2008) 1.11
The association between atopy and childhood/adolescent leukemia: a meta-analysis. Am J Epidemiol (2010) 1.09
In vitro replication and thermodynamic studies of methylation and oxidation modifications of 6-thioguanine. Nucleic Acids Res (2007) 0.93
Unusual aggressive course of a giant cell tumor of soft tissue during immunosuppressive therapy. Virchows Arch (2006) 0.82
Transgenic expression of P1A induced thymic tumor: a role for onco-fetal antigens in tumorigenesis. PLoS One (2010) 0.78
The scientific method: pillar and pitfall of cancer research. Cancer Med (2014) 0.78
Epstein-Barr virus in malignancies in renal transplant recipients in Japan. J Cancer Res Clin Oncol (1997) 0.77
De novo cancers following liver transplantation: a single center experience in China. PLoS One (2014) 0.77
Impaired T-Cell Function in B-Cell Lymphoma: A Direct Consequence of Events at the Immunological Synapse? Front Immunol (2015) 0.75
On the crossroad between tolerance and posttransplant lymphoma. Curr Opin Organ Transplant (1997) 0.75
Are We Late in the Diagnosis of Malignities Occurring in Solid Organ Transplant Patients? 11 Years' Experience. Eurasian J Med (2016) 0.75
The changing pattern of posttransplant malignancies. Transplant Proc (1991) 1.42
The problem of cancer in organ transplant recipients: an overview. Transplant Sci (1994) 1.22
Secondary neoplasms as a consequence of transplantation and cancer therapy. Cancer Detect Prev (1988) 1.15
Cancer in the immunosuppressed organ recipient. Transplant Proc (1991) 0.83